ENBREL (Immunex Corporation)
Welcome to the PulseAid listing for the ENBREL drug offered from Immunex Corporation. This Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Immunex Corporation |
| NON-PROPRIETARY NAME: | etanercept |
| SUBSTANCE NAME: | ETANERCEPT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2005-10-06 |
| END MARKETING DATE: | 0000-00-00 |
ENBREL HUMAN PRESCRIPTION DRUG Details:
| Item Description | ENBREL from Immunex Corporation |
| LABELER NAME: | Immunex Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/mL) |
| START MARKETING DATE: | 2005-10-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 58406-435_93b2cc40-ee24-4caf-8806-5b2b49b2bae4 |
| PRODUCT NDC: | 58406-435 |
| APPLICATION NUMBER: | BLA103795 |
Other ETANERCEPT Pharmaceutical Manufacturers / Labelers:
